| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1016127632 |
| P356 | DOI | 10.1038/NRG.2016.27 |
| P8608 | Fatcat ID | release_amz4r5hmxvfshbx7m5myxpke2e |
| P932 | PMC publication ID | 6021129 |
| P698 | PubMed publication ID | 27140283 |
| P50 | author | Nilanjan Chatterjee | Q21526241 |
| Montserrat García-Closas | Q28356305 | ||
| P2093 | author name string | Jianxin Shi | |
| P2860 | cites work | Joint effect of genes and environment distorted by selection biases: implications for hospital-based case-control studies. | Q52942908 |
| Neyman's bias re-visited. | Q52951585 | ||
| Reliability of self-reported family history of cancer in a large case-control study of lymphoma. | Q52997151 | ||
| Systematic Population-Based Assessment of Cancer Risk in First-Degree Relatives of Cancer Probands | Q59548851 | ||
| Projecting individualized probabilities of developing breast cancer for white females who are being examined annually | Q69396132 | ||
| Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies | Q72278250 | ||
| The inheritance of liability to diseases with variable age of onset, with particular reference to diabetes mellitus | Q72304054 | ||
| Polygenic susceptibility to breast cancer and implications for prevention | Q78029012 | ||
| A cohort study of cancer risk in relation to family histories of cancer in the Utah population database | Q81547804 | ||
| Public health implications from COGS and potential for risk stratification and screening | Q86499074 | ||
| Accurate and robust genomic prediction of celiac disease using statistical learning | Q21563352 | ||
| Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types | Q24170413 | ||
| Knowledge translation of research findings | Q24288915 | ||
| Biological insights from 108 schizophrenia-associated genetic loci | Q24561833 | ||
| PLINK: a tool set for whole-genome association and population-based linkage analyses | Q24677407 | ||
| Recent Enhancements to the Genetic Risk Prediction Model BRCAPRO | Q26995389 | ||
| Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland | Q28140600 | ||
| Common polygenic variation contributes to risk of schizophrenia and bipolar disorder | Q28250609 | ||
| Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials | Q28258442 | ||
| Meta-analysis of the heritability of human traits based on fifty years of twin studies | Q28262090 | ||
| 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines | Q28301815 | ||
| Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4 | Q29417143 | ||
| GCTA: a tool for genome-wide complex trait analysis | Q29547216 | ||
| Common SNPs explain a large proportion of the heritability for human height | Q29547221 | ||
| Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond | Q29614697 | ||
| Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction | Q30301147 | ||
| Building the evidence base for decision making in cancer genomic medicine using comparative effectiveness research | Q30419845 | ||
| Joint analysis of functional genomic data and genome-wide association studies of 18 human traits | Q30794057 | ||
| Estimation and partitioning of (co)heritability of inflammatory bowel disease from GWAS and immunochip data | Q30799619 | ||
| The genetic interpretation of area under the ROC curve in genomic profiling | Q33535887 | ||
| Gene-lifestyle interaction and type 2 diabetes: the EPIC interact case-cohort study | Q33638105 | ||
| The German National Cohort: aims, study design and organization | Q33729461 | ||
| Evidence for polygenic susceptibility to multiple sclerosis--the shape of things to come | Q33772946 | ||
| Familial Risk and Heritability of Cancer Among Twins in Nordic Countries | Q33874409 | ||
| A polygenic burden of rare disruptive mutations in schizophrenia | Q34060200 | ||
| MultiBLUP: improved SNP-based prediction for complex traits | Q34153795 | ||
| Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 women | Q34155371 | ||
| Estimating the proportion of variation in susceptibility to schizophrenia captured by common SNPs. | Q34255285 | ||
| Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2. | Q34314370 | ||
| Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors | Q34325802 | ||
| How can polygenic inheritance be used in population screening for common diseases? | Q34327946 | ||
| Power and predictive accuracy of polygenic risk scores. | Q34337027 | ||
| Improved detection of common variants associated with schizophrenia and bipolar disorder using pleiotropy-informed conditional false discovery rate | Q34342469 | ||
| Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium | Q34472668 | ||
| Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases | Q34478075 | ||
| The UK10K project identifies rare variants in health and disease | Q34494047 | ||
| Leveraging population admixture to characterize the heritability of complex traits | Q34572467 | ||
| Polygenic modeling with bayesian sparse linear mixed models | Q34585745 | ||
| Testing calibration of risk models at extremes of disease risk | Q34678258 | ||
| Estimating missing heritability for disease from genome-wide association studies | Q34687621 | ||
| All SNPs are not created equal: genome-wide association studies reveal a consistent pattern of enrichment among functionally annotated SNPs | Q34699776 | ||
| Measuring missing heritability: inferring the contribution of common variants | Q34709339 | ||
| Combined associations of genetic and environmental risk factors: implications for prevention of breast cancer | Q34736112 | ||
| Most common 'sporadic' cancers have a significant germline genetic component | Q34736858 | ||
| Using extended genealogy to estimate components of heritability for 23 quantitative and dichotomous traits | Q34758236 | ||
| Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors | Q34898735 | ||
| Novel genetic analysis for case-control genome-wide association studies: quantification of power and genomic prediction accuracy | Q34971277 | ||
| Predicting the risk of rheumatoid arthritis and its age of onset through modelling genetic risk variants with smoking | Q34998359 | ||
| Joint analysis of psychiatric disorders increases accuracy of risk prediction for schizophrenia, bipolar disorder, and major depressive disorder | Q35059381 | ||
| Two criteria for evaluating risk prediction models | Q35103714 | ||
| Risk prediction of complex diseases from family history and known susceptibility loci, with applications for cancer screening | Q35136955 | ||
| Sixty-five common genetic variants and prediction of type 2 diabetes | Q35532317 | ||
| The contribution of genetic variants to disease depends on the ruler | Q35547325 | ||
| An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort | Q35553113 | ||
| Simultaneous discovery, estimation and prediction analysis of complex traits using a bayesian mixture model | Q35596725 | ||
| Accuracy of reporting of family history of colorectal cancer | Q35598274 | ||
| A model to determine colorectal cancer risk using common genetic susceptibility loci | Q35655831 | ||
| The FDA and genomic tests--getting regulation right | Q35730574 | ||
| A framework for training health professionals in implementation and dissemination science | Q35839505 | ||
| Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers | Q35927436 | ||
| Inclusion of gene-gene and gene-environment interactions unlikely to dramatically improve risk prediction for complex diseases | Q36017113 | ||
| Potential usefulness of single nucleotide polymorphisms to identify persons at high cancer risk: an evaluation of seven common cancers | Q36097440 | ||
| Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores | Q36133352 | ||
| Gene-panel sequencing and the prediction of breast-cancer risk | Q36175072 | ||
| Lung Cancer Risk Prediction Using Common SNPs Located in GWAS-Identified Susceptibility Regions | Q36258075 | ||
| Improved heritability estimation from genome-wide SNPs | Q36451499 | ||
| Estimation and partitioning of polygenic variation captured by common SNPs for Alzheimer's disease, multiple sclerosis and endometriosis | Q36560009 | ||
| Prediction of breast cancer risk based on profiling with common genetic variants | Q36583004 | ||
| Comparison of self-reported and database-linked family history of cancer data in a case-control study | Q36874763 | ||
| Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer | Q36944260 | ||
| Projecting the performance of risk prediction based on polygenic analyses of genome-wide association studies | Q37059182 | ||
| Predicting risk of type 2 diabetes mellitus with genetic risk models on the basis of established genome-wide association markers: a systematic review | Q37220830 | ||
| Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysis | Q37315305 | ||
| BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface | Q37507410 | ||
| Challenges of translating genetic tests into clinical and public health practice | Q37511706 | ||
| Net reclassification indices for evaluating risk prediction instruments: a critical review | Q37569098 | ||
| Improving coeliac disease risk prediction by testing non-HLA variants additional to HLA variants | Q37600331 | ||
| Net risk reclassification p values: valid or misleading? | Q37696697 | ||
| Improving genetic risk prediction by leveraging pleiotropy | Q37705235 | ||
| Advantages and pitfalls in the application of mixed-model association methods | Q37706750 | ||
| A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance | Q37950847 | ||
| The contribution of rare variation to prostate cancer heritability | Q38856899 | ||
| Clinical implications of genomics for cancer risk genetics | Q38996690 | ||
| 5 year mortality predictors in 498,103 UK Biobank participants: a prospective population-based study | Q40863323 | ||
| Designing and analysing case-control studies to exploit independence of genotype and exposure | Q41572695 | ||
| Estimation of SNP heritability from dense genotype data | Q42842254 | ||
| Effective genetic-risk prediction using mixed models | Q42928984 | ||
| Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis | Q44921278 | ||
| Strategies for developing prediction models from genome-wide association studies | Q46953427 | ||
| Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award | Q48065999 | ||
| A genetic risk score of 45 coronary artery disease risk variants associates with increased risk of myocardial infarction in 6041 Danish individuals. | Q50566315 | ||
| What is the clinical utility of genetic testing? | Q52012351 | ||
| Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. | Q52041429 | ||
| Selection of controls in case-control studies. I. Principles | Q52861899 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prevention | Q1717246 |
| disease prevention | Q106807541 | ||
| P304 | page(s) | 392-406 | |
| P577 | publication date | 2016-05-03 | |
| P1433 | published in | Nature Reviews Genetics | Q1071824 |
| P1476 | title | Developing and evaluating polygenic risk prediction models for stratified disease prevention | |
| P478 | volume | 17 |
| Q92073801 | A New Era of Prostate Cancer Precision Medicine |
| Q89807403 | A framework for transcriptome-wide association studies in breast cancer in diverse study populations |
| Q92639275 | A practical view of fine-mapping and gene prioritization in the post-genome-wide association era |
| Q38654540 | A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone |
| Q64250131 | A review of lifestyle, metabolic risk factors, and blood-based biomarkers for early diagnosis of pancreatic ductal adenocarcinoma |
| Q90754603 | A systems approach to clinical oncology uses deep phenotyping to deliver personalized care |
| Q92972342 | Age-related late-onset disease heritability patterns and implications for genome-wide association studies |
| Q97070156 | Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers |
| Q57612089 | Association of Polygenic Risk Scores for Multiple Cancers in a Phenome-wide Study: Results from The Michigan Genomics Initiative |
| Q58578955 | Associations between polygenic risk scores for four psychiatric illnesses and brain structure using multivariate pattern recognition |
| Q90291761 | BDNF, COMT, and DRD2 polymorphisms and ability to return to work in adult patients with low- and high-grade glioma |
| Q91045517 | BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors |
| Q41243055 | Barriers and Facilitating Factors for Implementation of Genetic Services: A Public Health Perspective |
| Q91865303 | Benefits and limitations of genome-wide association studies |
| Q52624157 | Big Data's Role in Precision Public Health. |
| Q90423366 | Cancer Progress and Priorities: Lung Cancer |
| Q48148502 | Chromosome conformation signatures define predictive markers of inadequate response to methotrexate in early rheumatoid arthritis. |
| Q93386513 | Clinical epigenetics: seizing opportunities for translation |
| Q92528444 | Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification |
| Q63433280 | Complex Trait Prediction from Genome Data: Contrasting EBV in Livestock to PRS in Humans: Genomic Prediction |
| Q57166340 | Cost Analyses of Genomic Sequencing: Lessons Learned from the MedSeq Project |
| Q47251942 | Current Challenges and New Opportunities for Gene-Environment Interaction Studies of Complex Diseases |
| Q47135116 | Development of multivariable models to predict change in Body Mass Index within a clinical trial population of psychotic individuals |
| Q64124629 | Disease Heritability Inferred from Familial Relationships Reported in Medical Records |
| Q30241340 | Dissecting the genetics of complex traits using summary association statistics |
| Q97692500 | Effects of polygenic risk for Alzheimer's disease on rate of cognitive decline in normal aging |
| Q91941941 | Efficient Implementation of Penalized Regression for Genetic Risk Prediction |
| Q90814829 | Electronic health records and polygenic risk scores for predicting disease risk |
| Q38605415 | Embracing polygenicity: a review of methods and tools for psychiatric genetics research. |
| Q90929499 | Estimation of complex effect-size distributions using summary-level statistics from genome-wide association studies across 32 complex traits |
| Q58657038 | Ethical, Legal, and Regulatory Issues for the Implementation of Omics-Based Risk Prediction of Women's Cancer: Points to Consider |
| Q92126870 | Evaluating the Potential of Younger Cases and Older Controls Cohorts to Improve Discovery Power in Genome-Wide Association Studies of Late-Onset Diseases |
| Q90093635 | Evaluating the promise of inclusion of African ancestry populations in genomics |
| Q102075603 | Functionally informed fine-mapping and polygenic localization of complex trait heritability |
| Q99633744 | Gene panel screening for insight towards breast cancer susceptibility in different ethnicities |
| Q91952526 | Genetic Associations Between Childhood Psychopathology and Adult Depression and Associated Traits in 42 998 Individuals: A Meta-Analysis |
| Q92018322 | Genetic Risk Scores for Diabetes Diagnosis and Precision Medicine |
| Q47945968 | Genetic Test, Risk Prediction, and Counseling. |
| Q97643246 | Genetic architecture of complex traits and disease risk predictors |
| Q36316307 | Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score |
| Q59340592 | Genetic disease risks can be misestimated across global populations |
| Q50036859 | Genetic hitchhiking and population bottlenecks contribute to prostate cancer disparities in men of African descent. |
| Q47573242 | Genetic overlap between epilepsy and schizophrenia: Evidence from cross phenotype analysis in Hong Kong Chinese population |
| Q55311806 | Genetic risk for neurodegenerative disorders, and its overlap with cognitive ability and physical function. |
| Q100407592 | Genetic risk, incident gastric cancer, and healthy lifestyle: a meta-analysis of genome-wide association studies and prospective cohort study |
| Q47207156 | Genetic variants demonstrating flip-flop phenomenon and breast cancer risk prediction among women of African ancestry |
| Q47933638 | Genetics of Anorexia Nervosa |
| Q39456531 | Genetics of Schizophrenia: Ready to Translate? |
| Q34553141 | Genetics of coronary artery disease: discovery, biology and clinical translation |
| Q90950429 | Genomic Prediction of 16 Complex Disease Risks Including Heart Attack, Diabetes, Breast and Prostate Cancer |
| Q64236058 | Genomic Predictors of Asthma Phenotypes and Treatment Response |
| Q57457932 | Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults: Implications for Primary Prevention |
| Q90975802 | Genomic prediction of depression risk and resilience under stress |
| Q102220492 | Genomics of hypertension: the road to precision medicine |
| Q55518822 | GlobAl Distribution of GEnetic Traits (GADGET) web server: polygenic trait scores worldwide. |
| Q92052787 | HLA associations in inflammatory arthritis: emerging mechanisms and clinical implications |
| Q64092231 | Health professionals' perspectives on breast cancer risk stratification: understanding evaluation of risk versus screening for disease |
| Q41978253 | Human Demographic History Impacts Genetic Risk Prediction across Diverse Populations |
| Q60300887 | Hypertension genetic risk score is associated with burden of coronary heart disease among patients referred for coronary angiography |
| Q36370330 | IGESS: A Statistical Approach to Integrating Individual-Level Genotype Data and Summary Statistics in Genome-Wide Association Studies. |
| Q87996412 | Implementation of personalized medicine in Central-Eastern Europe: pitfalls and potentials based on citizen's attitude |
| Q91198216 | Improved polygenic prediction by Bayesian multiple regression on summary statistics |
| Q52668588 | Improving genetic prediction by leveraging genetic correlations among human diseases and traits. |
| Q103806769 | Improving the trans-ancestry portability of polygenic risk scores by prioritizing variants in predicted cell-type-specific regulatory elements |
| Q57178727 | Insights into clonal haematopoiesis from 8,342 mosaic chromosomal alterations |
| Q90266297 | Integration of Machine Learning Methods to Dissect Genetically Imputed Transcriptomic Profiles in Alzheimer's Disease |
| Q39238156 | Integrative genetic risk prediction using non-parametric empirical Bayes classification |
| Q64066372 | Jackknife Model Averaging Prediction Methods for Complex Phenotypes with Gene Expression Levels by Integrating External Pathway Information |
| Q64279327 | Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk |
| Q47190168 | Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium |
| Q33829049 | Joint modeling of genetically correlated diseases and functional annotations increases accuracy of polygenic risk prediction |
| Q33825680 | Leveraging functional annotations in genetic risk prediction for human complex diseases |
| Q97555573 | Leveraging large genomic datasets to illuminate the pathobiology of autism spectrum disorders |
| Q91612431 | Liver stiffness assessed by transient elastography as a potential indicator of chronic kidney disease in patients with nonalcoholic fatty liver disease |
| Q108126970 | Machine Learning Prediction of Biomarkers from SNPs and of Disease Risk from Biomarkers in the UK Biobank |
| Q47594518 | Making fair comparisons in pregnancy medication safety studies: An overview of advanced methods for confounding control. |
| Q37283218 | Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer |
| Q89614848 | Mouse Systems Genetics as a Prelude to Precision Medicine |
| Q90002991 | Multi-omic biomarker identification and validation for diagnosing warzone-related post-traumatic stress disorder |
| Q46496028 | Multiethnic polygenic risk scores improve risk prediction in diverse populations. |
| Q40054865 | Non-parametric genetic prediction of complex traits with latent Dirichlet process regression models. |
| Q55216467 | POLARIS: Polygenic LD-adjusted risk score approach for set-based analysis of GWAS data. |
| Q96577047 | Personalized early detection and prevention of breast cancer: ENVISION consensus statement |
| Q33590424 | Phenome-wide heritability analysis of the UK Biobank |
| Q64461064 | Polygenic Prediction of Weight and Obesity Trajectories from Birth to Adulthood |
| Q89678432 | Polygenic Risk Scores and Physical Activity |
| Q52630895 | Polygenic Risk Scores in Clinical Psychology: Bridging Genomic Risk to Individual Differences. |
| Q92287495 | Polygenic Susceptibility of Aortic Aneurysms Associates to the Diameter of the Aneurysm Sac: the Aneurysm-Express Biobank Cohort |
| Q91788154 | Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers |
| Q98611548 | Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions |
| Q47561710 | Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts |
| Q64109912 | Polygenic prediction via Bayesian regression and continuous shrinkage priors |
| Q91771798 | Polygenic risk scores for Alzheimer's disease, and academic achievement, cognitive and behavioural measures in children from the general population |
| Q47889697 | Posttraumatic stress disorder symptom severity is associated with reduced default mode network connectivity in individuals with elevated genetic risk for psychopathology. |
| Q38820915 | Precisely Where Are We Going? Charting the New Terrain of Precision Prevention. |
| Q37390560 | Precision Medicine: What Challenges Are We Facing? |
| Q91791147 | Precision neuroradiology: mapping the nodes and networks that link genes to behaviour |
| Q39282504 | Precision reproductive medicine: multigene panel testing for infertility risk assessment |
| Q58760135 | Prediction model for pancreatic cancer risk in the general Japanese population |
| Q33660160 | Prediction of gene expression with cis-SNPs using mixed models and regularization methods |
| Q47409320 | Predictive accuracy of combined genetic and environmental risk scores |
| Q48373157 | Prioritising the application of genomic medicine |
| Q92683687 | Progress in Polygenic Composite Scores in Alzheimer's and Other Complex Diseases |
| Q91746992 | Quantifying the Potential for Future Gene Therapy to Lower Lifetime Risk of Polygenic Late-Onset Diseases |
| Q90950265 | Quantifying the polygenic contribution to variable expressivity in eleven rare genetic disorders |
| Q57059979 | Renal compartment-specific genetic variation analyses identify new pathways in chronic kidney disease |
| Q37663150 | Risk Model for Colorectal Cancer in Spanish Population Using Environmental and Genetic Factors: Results from the MCC-Spain study. |
| Q38711992 | Risk Stratification for Second Primary Lung Cancer |
| Q36326970 | Risk prediction of pulmonary tuberculosis using genetic and conventional risk factors in adult Korean population |
| Q49726138 | Semiparametric analysis of complex polygenic gene-environment interactions in case-control studies. |
| Q98237660 | Sibling validation of polygenic risk scores and complex trait prediction |
| Q36350018 | Stratified polygenic risk prediction model with application to CAGI bipolar disorder sequencing data. |
| Q94474369 | The ChinaMAP analytics of deep whole genome sequences in 10,588 individuals |
| Q47355032 | The RA-MAP Consortium: a working model for academia-industry collaboration. |
| Q89687104 | The Translational Potential of Neuroimaging Genomic Analyses To Diagnosis And Treatment In The Mental Disorders |
| Q39248311 | The association between miR-423 rs6505162 polymorphism and cancer susceptibility: a systematic review and meta-analysis |
| Q96230855 | The effect of sample size on polygenic hazard models for prostate cancer |
| Q92453423 | The genetics of bipolar disorder |
| Q58786509 | The impact of genome-wide association studies on biomedical research publications |
| Q88778863 | The personal and clinical utility of polygenic risk scores |
| Q50044283 | The surprising implications of familial association in disease risk. |
| Q47553776 | The value of polygenic analyses in psychiatry |
| Q57170901 | Trans-Ethnic Polygenic Analysis Supports Genetic Overlaps of Lumbar Disc Degeneration With Height, Body Mass Index, and Bone Mineral Density |
| Q50084006 | Trans-ethnic Evaluation Identifies Novel Low Frequency Loci Associated with 25-Hydroxyvitamin D Concentrations. |
| Q38626073 | Transcriptional risk scores link GWAS to eQTLs and predict complications in Crohn's disease |
| Q38992297 | Translating genome-wide association findings into new therapeutics for psychiatry |
| Q90580816 | Using whole genome scores to compare three clinical phenotyping methods in complex diseases |
| Q92537538 | Utility and First Clinical Application of Screening Embryos for Polygenic Disease Risk Reduction |
| Q49547910 | Validation of Polygenic Scores for QT Interval in Clinical Populations. |
| Q28917124 | Winner's Curse Correction and Variable Thresholding Improve Performance of Polygenic Risk Modeling Based on Genome-Wide Association Study Summary-Level Data |
Search more.